Active surveillance of early prostate cancer: rationale, initial results and future developments
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Urology,Oncology
Link
http://www.nature.com/articles/4500720.pdf
Reference19 articles.
1. Albertsen PC, Hanley JA, Gleason DF, Barry MJ . Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 1998; 280: 975–980.
2. Chodak GW et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994; 330: 242–248.
3. Johansson JE et al. Fifteen-Year survival in prostate cancer. A prospective, population- based study in Sweden. JAMA 1997; 277: 467–471.
4. Draisma G et al. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 2003; 95: 868–878.
5. Etzioni R et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 2002; 94: 981–990.
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Interaction of MRI and active surveillance in prostate cancer: Time to re-evaluate the active surveillance inclusion criteria;Urologic Oncology: Seminars and Original Investigations;2021-09
2. Patients Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer;The Annals of Family Medicine;2016-05-01
3. The experience of adults who choose watchful waiting or active surveillance as an approach to medical treatment: a qualitative systematic review;JBI Database of Systematic Reviews and Implementation Reports;2016-02
4. The experience of adults who choose watchful waiting or medical surveillance as an approach to medical treatment: a qualitative systematic review protocol;JBI Database of Systematic Reviews and Implementation Reports;2015-02
5. Is Focal Prostate Therapy Just Psychotherapy? Surveillance Versus Focal Therapy: Pros and Cons;Focal Therapy of Prostate Cancer;2015
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3